Juthaporn Cowan profile picture

Contact Information

Juthaporn Cowan, MD, PhD, FRCPC
(613)737-8899 ext. 79617

Administrative Coordinator:
Andrea Trinidad
atrinidad@toh.ca

ORCID logo https://orcid.org/0000-0001-6648-5109

Publications

Selected Publications

Ieta, S., Ivory, C., Cowan, J. (2022). Duration of prednisone treatment before development of Pneumocystis jerovecii pneumonia in patients with vasculitis: A Case Series. Journal of the Association of Medical Microbiology and Infectious Disease Canada. DOI: https://doi.org/10.3138/jammi-2021-0031

Cowan. J., Mulpuru, S., Abdallah, S., Chopra, A., Purssell, A., McGuinty, M., Alvarez, G., Giulivi, A., Corrales-Medina, V., MacFadden, D., Boyle, L., Hasimja, D., Thavorn, K., Mallick, R., Aaron, S., Cameron, DW. (2021). A randomized double-blind placebo-control feasibility trial of immunoglobulin treatment for prevention of recurrent acute exacerbations of COPD. International Journal of COPD. 16, 3275-3284. DOI:10.2147/COPD.S338849

Patel, V., Cameron, D.W., Cowan, J. (2021). Immunoglobulin Replacement Therapy Discontinuation in Patients with Antibody Deficiency Secondary to Hematological Malignancy: A Single-Center Study. Hematological Oncology. DOI: 10.1002/hon.2900

Poenaru, S., Abdallah, S.J., Corrales-Medina, V., Cowan, J. (2021). COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: A narrative review. Therapeutic Advances in Infectious Disease. DOI: 10.1177/20499361211009385

Abdallah, S., Voduc, N., Corrales-Medina, V., McGuinty, M., Pratt, A., Chopra, A., Law, A., Garuba, H., Thavorn, K., Reid, R., Lavoie, K., Crawley, A., Chirinos, J., Cowan, J. (2021). Symptoms, pulmonary function and functional capacity four months after COVID-19. Annals of the American Thoracic Society. DOI: 10.1513/AnnalsATS.202012-1489RL

All Other Publications

Unninayar, D., Abdallah, S., Cameron, D.W., Cowan, J. (2021). Polyvalent immunoglobulin as a potential treatment option for patients with recurrent COPD exacerbations. International Journal of Chronic Obstructive Pulmonary Disease.16:545-552. DOI: 10.2147/COPD.S283832

Cowan, J., Bonagura, V., Lugar, P., Maglione, P., Patel, N., Vinh, D., Hofmann, J., Praus, M., Rojavin, M. (2020). Safety and tolerability of manual push administration of subcutaneous IgPro20 at high infusion rates in patients with primary immunodeficiency: findings from the manual push administration cohort of the HILO study. Journal of Clinical Immunology. 40(7):1-10. DOI 10.1007/s10875-020-00876-6

Patel, V., Cowan, J. (2020) Discontinuation of immunoglobulin replacement therapy in patients with secondary antibody deficiency. Expert Review of Clinical Immunology. 16(7):711-716. DOI: 10.1080/1744666X.2020.1788939

Thabet, C., Sherazi, A., Cowan, J. (2020). Toxoplasmosis, Cryptosporidiosis, and Isosporiasis in Non-HIV Immunocompromised Patients, a single-center study, Ottawa, Canada. Journal of the Association of Medical Microbiology and Infectious Disease Canada. 5(4):239-244. Doi: 10.3138/jammi-2020-0024

Suleman, A., Cameron, D.W., Corrales-Medina, V., McCudden, C., Cowan, J. (2020). Evaluation of the protein gap for detection of abnormal serum gammaglobulin level: an imperfect predictor. Clinical Chemistry and Laboratory Medicine (CCLM). Published online19 Nov 2020. https://doi.org/10.1515/cclm-2020-1286

Patel, V., Cowan, J. (2020) Discontinuation of immunoglobulin replacement therapy in patients with secondary antibody deficiency. Expert Review of Clinical Immunology. 16(7):711-716. DOI: 10.1080/1744666X.2020.1788939

Patel, V., Desjardins, M., Cowan, J. (2019). Shift in epidemiology of cryptococcal infections in Ottawa with high mortality in non-HIV immunocompromised patients. J Fungi. 10:5(4): pii:E104. Doi: 10.3390/jof5040104

Dinh, T., Oh, J., Cameron, DW, Lee SH, Cowan, J. (2019). Differential immunomodulation of T-cells by immunoglobulin replacement therapy in primary and secondary antibody deficiency. PLOS ONE. 14(10):e0223861. DOI: 10.1371/journal.pone.0223861

Suleman, A., Padmore, R., Faught, C, Cowan, J. (2019). Disseminated cryptococcal infection in a patient with treatment-naïve chronic lymphocytic leukemia (CLL). IDCases. E00566. DOI: 10.1016/j.idcr.2019. e00566

Bourassa-Blanchette, S., Patel, V., Knoll, G., Hutton, B., Fergusson, N., Bennett, A., Tay. J., Cameron, D.W., Cowan, J. (2019). Clinical outcomes of polyvalent immunoglobulin use in solid organ transplant recipients: a systematic review and meta-analysis. Part II: Non-kidney transplant. Clinical Transplantation.e13625. DOI: 10.1111/ctr.13625

Bourassa-Blanchette, S., Knoll, G., Hutton, B., Fergusson, N., Bennett, A., Tay, J., Cameron, DW., Cowan, J. (2019). Clinical outcomes of polyvalent immunoglobulin use in solid organ transplant recipients: a systematic review and meta-analysis. Part I: kidney transplant. Clinical Transplantation. e13560. DOI: 10.1111/ctr.13560

Suleman, A., Theoret, L., Bourque, P., Pringle, E., Cameron, DW., Cowan, J. (2018). Evaluation of a personalized subcutaneous immunoglobulin treatment program for neurological patients. Canadian Journal of Neurological Sciences. 46(1):38-43. DOI: 10.1017/cjn.2018.363

Ahn, H., Tay, J., Shea, B., Hutton, B., Shorr, R., Knoll, G., Cameron, B, Cowan, J. (2018). Effectiveness of immunoglobulin prophylaxis in reducing clinical complications of hematopoietic stem cell transplantation: a systematic review and meta-analysis. Transfusion. 58(10):2437-2452. DOI: 10.1111/trf.14656

Cowan, J., Mulpuru, S., Aaron, S., Alvarez, G., Giulivi, A., Corrales-Medina, V., Thiruganasambandamoorthy, V., Thavorn, K., Mallick, R., Cameron, DW. (2018). Study protocol: a randomized, double blind, parallel, two-arm, placebo control trial investigating the feasibility and safety of immunoglobulin treatment in COPD patients for prevention of frequent recurrent exacerbations. Pilot and Feasibility. DOI: 10.1186/s40814-018-0327-z

Cowan, J., Bennett, A., Fergusson, N, McLean, C., Mallick, R., Cameron, DW., Knoll, G. (2018). Incidence rate of post-kidney transplant infection: a retrospective cohort study examining infection rates at a large Canadian multicenter tertiary-care facility. Canadian Journal of Kidney Health and Disease. DOI: 10.1177/2054358118799692

Cowan, J., Do, T.L., Desjardins, S., Ramotar, K., Corrales-Medina, V., Cameron, D. W. (2018). Prevalence of hypogammaglobulinemia in adult invasive pneumococcal disease. Clinical Infectious Disease. 66(4):564-569. DOI: 10.1093/cid/cix836

Cowan, J.
, Mulpuru, S., Alvarez, G., Corrales-Medina, V., Cameron, D.W. (2017). COPD exacerbation frequency and serum immunoglobulin G levels. Journal of Allergy and Clinical Immunology. 141(2):830-831. DOI: 10.1016/j.jaci.2017.09.036

Bourassa-Blanchette, S., Knoll, G., Tay, J., Bredeson, C., Cameron, D.W., Cowan, J. (2017). A national survey of screening and management of hypogammaglobulinemia in Canadian transplantation centres. Transplant Infectious Disease. 19(4). DOI: 10.1111/tid.12706

Bourque, PR., Pringle, CE., Cameron, W., Cowan, J., Chardon, JW. (2016). Subcutaneous Immunoglobulin Therapy in the Chronic Management of Myasthenia Gravis: A Retrospective Cohort Study. PLoS ONE. 11(8): e0159993. DOI:10.1371/journal.pone.0159993

Cowan, J., Hutton, B., Fergusson, N., Bennett, A., Tay, J., Cameron, DW., Knoll, G. (2015). Clinical outcomes of immunoglobulin use in solid organ transplant recipients: protocol for a systematic review and meta-analysis. Systematic Reviews. 4(167). DOI:10.1186/s13643-015-0156-6

Cowan, J., Gaudet, L., Mulpuru, S., Corrales-Medina, V., Hawken, S., Cameron, C., Aaron, S.D., Cameron, DW. (2015). A retrospective longitudal within-subject risk interval analysis of immunoglobulin treatment for recurrent acute exacerbation of chronic obstructive pulmonary disease. PLoS ONE. 10(11):e0142205. DOI:10.1371/journal.pone.0142205.eCollection 2015.

Cowan, J., Cameron, DW., Knoll, G., Tay. J. (2015). Protocol for updating a systematic review of randomised controlled trials on the prophylactic use of intravenous immunoglobulin for patients undergoing haematopoietic stem cell transplantation. BMJ Open. Aug 21; 5(8):e008316. DOI:10.1136/bmjopen-2015-008316

Alomari, A., Cowan, J., Turner, L., Cooper, C. (2013). Antidepressant prophylaxis reduces depression risk but does not improve sustained virological response in hepatitis C interferon recipients without depression at baseline: a systematic review and meta-analysis. Canadian Journal of Gastroenterology. 27(10):575-81

Cowan, J., Panday, S., Filion, LG., Angel, JB., Kumar, A., Cameron DW. (2012) Comparison of interferon-γ-, interleukin (IL)-17- and IL-22-expressing CD4 T cells, IL-22-expressing granulocytes and proinflammatory cytokines during latent and active tuberculosis infection. Clinical and Experimental Immunology,167(2):317-29. DOI: 10.1111/j.1365-2249.2011.04520.x

Cowan (Kohwiwattanagun), J., Kawamura, I., Mitsuyama, M. (2007). Mycobacterial mammalian cell entry protein 1A (Mce1A) - mediated adherence enhances chemokine production from A549 cells. Microbiology and immunology, 51(2), 253-261.